| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/22/2010 | WO2010045024A1 Biomarkers and methods for detecting and treating spinal and joint pain |
| 04/22/2010 | WO2010044919A2 Smallpox dna vaccine and the antigens therein that elicit an immune response |
| 04/22/2010 | WO2010044917A1 Compositions for the prevention and treatment of neuroinjury and methods of use thereof |
| 04/22/2010 | WO2010044894A1 Methods and compositions for treatment of myotonic dystrophy |
| 04/22/2010 | WO2010044867A1 Highly concentrated drug particles, formulations, suspensions and uses thereof |
| 04/22/2010 | WO2010044803A1 Treatment of amyloidogenic diseases |
| 04/22/2010 | WO2010044691A1 Immunosuppressive peptide |
| 04/22/2010 | WO2010044529A1 Use of a protein for enhancing memory |
| 04/22/2010 | WO2010044474A1 Therapeutic agent for hepatitis c |
| 04/22/2010 | WO2010044095A2 Novel immunologically active peptide fragments of a proline- rich polypeptide isolated from mammalian colostrums for treatment of viral and non-viral diseases or diseased conditions |
| 04/22/2010 | WO2010043972A2 Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury |
| 04/22/2010 | WO2010043772A2 Method of protecting cells |
| 04/22/2010 | WO2010043582A1 Method for the treatment of cancer |
| 04/22/2010 | WO2010043444A2 Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof |
| 04/22/2010 | WO2010043153A1 Fusion protein inhibiting osteoclast formation, preparation method and drug compositions thereof |
| 04/22/2010 | WO2010043073A1 Collagen polypeptide, preparation method and uses thereof |
| 04/22/2010 | WO2010043047A1 Conjugates of glp-1 agonists and uses thereof |
| 04/22/2010 | WO2010043046A1 Peptide inhibitors of type iii secretion |
| 04/22/2010 | WO2010043045A1 Annexin and its use to treat inflammatory disorders |
| 04/22/2010 | WO2010042997A1 Compositions and methods for treatment of kidney disorders |
| 04/22/2010 | WO2010027802A9 Methods for treating diabetic wounds |
| 04/22/2010 | WO2010019963A3 Na channels, disease, and related assays and compositions |
| 04/22/2010 | WO2010017912A3 Use of human hyaluronidases for axonal regrowth |
| 04/22/2010 | WO2010014176A3 Preparation method of biodegradable micro-particles containing drugs |
| 04/22/2010 | WO2010013191A3 Cosmetic composition and process for regrowth of integumentary system |
| 04/22/2010 | WO2010011533A3 Compositions and methods for increasing serum antioxidant concentrations |
| 04/22/2010 | WO2010009985A3 Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents |
| 04/22/2010 | WO2010007622A3 Long-acting interferons and derivatives thereof and methods thereof |
| 04/22/2010 | WO2010003002A3 Modulation of follicular helper t cells |
| 04/22/2010 | WO2010002583A3 Natriuretic polypeptides with unique pharmacologic profiles |
| 04/22/2010 | WO2009155932A3 Modulation of the trpv : vps10p-domain receptor system for the treatment of pain |
| 04/22/2010 | WO2009155366A3 Improved peptide mediators of cholesterol efflux |
| 04/22/2010 | WO2009152247A3 Thrombopoietic activity of tyrosyl-trna synthetase polypeptides |
| 04/22/2010 | WO2009151714A3 Therapeutic for treatment of circulatory shock, ischemia, inflammatory disease and related conditions |
| 04/22/2010 | WO2009149278A8 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 04/22/2010 | WO2009132401A3 Citrullinated cytokines |
| 04/22/2010 | WO2009128918A8 Combination therapy using a soluble hyaluronidase and a bisphosphonate |
| 04/22/2010 | WO2009043450A8 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents |
| 04/22/2010 | WO2009029601A3 Receptor-targeting reagents |
| 04/22/2010 | WO2009025743A3 Use of trail compositions as antiviral agents |
| 04/22/2010 | US20100099850 Human cytokine receptor |
| 04/22/2010 | US20100099843 Dolastatin 15 derivatives |
| 04/22/2010 | US20100099750 Chemically modified short interfering nucleic acid molecule for use in treatment of respiratory and pulmonary disease |
| 04/22/2010 | US20100099748 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes |
| 04/22/2010 | US20100099742 Sensitizing Cells for Apoptosis by Selectively Blocking Cytokines |
| 04/22/2010 | US20100099740 Methods and compositions for rnai mediated inhibition of gene expression in mammals |
| 04/22/2010 | US20100099657 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity |
| 04/22/2010 | US20100099629 Ophthalmological composition |
| 04/22/2010 | US20100099628 Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue |
| 04/22/2010 | US20100099627 Nuclear targeting sequences |
| 04/22/2010 | US20100099626 Cell penetrating peptides for intracellular delivery of molecules |
| 04/22/2010 | US20100099625 Bio-security system |
| 04/22/2010 | US20100099622 Wound healing |
| 04/22/2010 | US20100099621 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| 04/22/2010 | US20100099620 Protracted GLP-1 Compositions |
| 04/22/2010 | US20100099619 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 04/22/2010 | US20100099618 Interleukin-9 and Interleukin-4 Chimeric Antagonist Muteins and Methods of Using Same |
| 04/22/2010 | US20100099617 Secreted proteins |
| 04/22/2010 | US20100099616 Modified blood factors comprising a low degree of water soluble polymer |
| 04/22/2010 | US20100099615 Pancreatic regenerating protein i in chronic pancreatitis and aging implications for new therapeutic approaches to diabetes |
| 04/22/2010 | US20100099614 Antimicrobial Peptides and Methods of Use |
| 04/22/2010 | US20100099613 Peptides for inducing a ctl and/or htl response to hepatitis c virus |
| 04/22/2010 | US20100099612 treating cancer responsive to interferon alpha therapy; the protein is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b) |
| 04/22/2010 | US20100099611 Anti-angiogenic peptides |
| 04/22/2010 | US20100099610 Transglutaminase Variants with Improved Specificity |
| 04/22/2010 | US20100099609 eAPP AND DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE |
| 04/22/2010 | US20100099608 Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor |
| 04/22/2010 | US20100099607 Casein complexes |
| 04/22/2010 | US20100099606 Effective use method of medicaments and method of preventing expression of side effect |
| 04/22/2010 | US20100099605 Chaperonin 10 immunosuppression |
| 04/22/2010 | US20100099604 Peptidic and non peptidic ligands for immunodetection of the receptor for urotensin |
| 04/22/2010 | US20100099603 Lyophilized recombinant vwf formulations |
| 04/22/2010 | US20100099602 Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury |
| 04/22/2010 | US20100099601 Fibrillation-resistant insulin and insulin analogues |
| 04/22/2010 | US20100099600 Candidates against infection |
| 04/22/2010 | US20100098778 Compositions and Methods for Controlling The Weight of Animals |
| 04/22/2010 | US20100098775 Detecting genetic predisposition to osteoarthritis associated conditions |
| 04/22/2010 | US20100098770 Sirolimus pharmaceutical formulations |
| 04/22/2010 | US20100098769 Synthetic Peptides Reducing or Removing Bags Formed Under the Lower Eye Contour and Their Use in Cosmetic or Dermopharmaceutical Compositions |
| 04/22/2010 | US20100098767 Convection enhanced delivery apparatus, method, and application |
| 04/22/2010 | US20100098762 Thermosensitive Pluronic Derivative Hydrogels With High Biodegradability And Biocompatibility For Tissue Regeneration And Preparation Method Thereof |
| 04/22/2010 | US20100098760 Polypeptide for treating or preventing adhesions |
| 04/22/2010 | US20100098752 Materials and Methods for Delivering Antioxidants into the Skin |
| 04/22/2010 | US20100098750 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 04/22/2010 | US20100098748 Arg-Gly-Asp (RGD) Sequence Containing Cyclic Peptide and Its Active Targeting Liposomes |
| 04/22/2010 | US20100098738 Surface bound actives |
| 04/22/2010 | US20100098737 methods and compositions for delivery of glycopeptide antibiotics to medical device surfaces |
| 04/22/2010 | US20100098732 Methods, processes and compositions comprising the protein calmodulin (cam) for treatment of damaged or aging skin, and/or hair loss |
| 04/22/2010 | US20100098727 Methods for treating eye disorders |
| 04/22/2010 | US20100098718 Nucleic acid vectors for immunization |
| 04/22/2010 | US20100098717 Polypeptides Recognized by Anti-Trichinella Antibodies, and Uses Thereof |
| 04/22/2010 | US20100098716 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 04/22/2010 | US20100098715 Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders |
| 04/22/2010 | US20100098713 Drug screening; assay for aldehyde dehydrogenase activity; cancer |
| 04/22/2010 | US20100098703 Determination of am-binding proteins and the association of adrenomedullin (am) therewith |
| 04/22/2010 | US20100098702 Method of treating androgen independent prostate cancer |
| 04/22/2010 | US20100098699 Methods of using LRR superfamily genes and proteins |
| 04/22/2010 | US20100098697 Chlamydia trachomatis antigens |
| 04/22/2010 | US20100098689 4-1 bb ligand in inflammatory diseases |
| 04/22/2010 | US20100098686 Method for reducing levels of C-reactive protein |